A mechanistic compartmental model integrating menstrual fluid binding data estimated that less than 0.3% of theoretically released lead from tampons would be available for vaginal tissue absorption under a four-hour wear scenario.

A Reddit thread among clinicians revisits the persistent gap between cervical neuroanatomy and analgesic practice during colposcopy, with peer perspectives reflecting evolving expectations around procedural pain.

An international consensus involving more than 14,000 patients and health professionals renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its endocrine and metabolic features.

A clinical review outlines how OBGYNs can integrate GLP-1 receptor agonist therapy into obesity care for women of reproductive age, with attention to fertility, contraception, and adherence.

Lerochol (lerodalcibep-liga), a once-monthly self-administered PCSK9 inhibitor, is now commercially available as adjunctive LDL-C-lowering therapy for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.

A single-institution case series of 13 biopsy-proven hydroxychloroquine cardiomyopathy patients documented variable outcomes after drug cessation, ranging from full functional recovery to progression requiring advanced heart failure therapies.